img

Global Androgen Antagonist Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Androgen Antagonist Market Insights, Forecast to 2034

An androgen antagonist is a drug that blocks the effects of androgens, such as testosterone and dihydrotestosterone (DHT). Androgens are male sex hormones that play a role in many bodily functions, including sexual development, muscle growth, and bone density.
Androgen antagonists are also known as antiandrogens. They work by blocking androgens from binding to androgen receptors in cells. This prevents androgens from exerting their effects on those cells.
Market Analysis and InsightsGlobal Androgen Antagonist Market
Global Androgen Antagonist market is expected to reach to US$ 7200 million in 2023, with a positive growth of %, compared with US$ 6650 million in 2022. Backed with the increasing demand from downstream industries, Androgen Antagonist industry is evaluated to reach US$ 9984.3 million in 2033. The CAGR will be 5.6% during 2023 to 2033.
The growth of the market is attributed to the increasing prevalence of prostate cancer, the rising demand for effective treatments for prostate cancer, and the growing awareness of the benefits of androgen antagonist therapy.
Increasing prevalence of prostate cancer
Rising demand for effective treatments for prostate cancer
Growing awareness of the benefits of androgen antagonist therapy
Increasing government investments in cancer research and development
Technological advancements in androgen antagonist drug discovery and development
The androgen antagonist market is expected to continue to grow in the coming years, driven by the factors mentioned above.
Report Covers
This report presents an overview of global Androgen Antagonist market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Androgen Antagonist market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Pfizer
Johnson & Johnson
AstraZeneca
Astellas
Merck
Sanofi
Orion Corporation
Hengrui
Bayer
Schering-Plough
Hinova Pharma
Jiangsu Hengrui Pharmaceuticals
Segment by Type
Steroidal Androgen Antagonist
Nonsteroidal Androgen Antagonist

Segment by Application


Prostate Cancer
Benign Prostatic Hyperplasia
Polycystic Ovary Syndrome (POCS)
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Androgen Antagonist introduction, etc. Androgen Antagonist Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Androgen Antagonist
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Androgen Antagonist Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Steroidal Androgen Antagonist
1.2.3 Nonsteroidal Androgen Antagonist
1.3 Market by Application
1.3.1 Global Androgen Antagonist Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Prostate Cancer
1.3.3 Benign Prostatic Hyperplasia
1.3.4 Polycystic Ovary Syndrome (POCS)
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Androgen Antagonist Market Perspective (2018-2033)
2.2 Global Androgen Antagonist Growth Trends by Region
2.2.1 Androgen Antagonist Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Androgen Antagonist Historic Market Size by Region (2018-2023)
2.2.3 Androgen Antagonist Forecasted Market Size by Region (2024-2033)
2.3 Androgen Antagonist Market Dynamics
2.3.1 Androgen Antagonist Industry Trends
2.3.2 Androgen Antagonist Market Drivers
2.3.3 Androgen Antagonist Market Challenges
2.3.4 Androgen Antagonist Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Androgen Antagonist by Players
3.1.1 Global Androgen Antagonist Revenue by Players (2018-2023)
3.1.2 Global Androgen Antagonist Revenue Market Share by Players (2018-2023)
3.2 Global Androgen Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Androgen Antagonist, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Androgen Antagonist Market Concentration Ratio
3.4.1 Global Androgen Antagonist Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Androgen Antagonist Revenue in 2022
3.5 Global Key Players of Androgen Antagonist Head office and Area Served
3.6 Global Key Players of Androgen Antagonist, Product and Application
3.7 Global Key Players of Androgen Antagonist, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Androgen Antagonist Breakdown Data by Type
4.1 Global Androgen Antagonist Historic Market Size by Type (2018-2023)
4.2 Global Androgen Antagonist Forecasted Market Size by Type (2024-2033)
5 Androgen Antagonist Breakdown Data by Application
5.1 Global Androgen Antagonist Historic Market Size by Application (2018-2023)
5.2 Global Androgen Antagonist Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Androgen Antagonist Market Size (2018-2033)
6.2 North America Androgen Antagonist Market Size by Type
6.2.1 North America Androgen Antagonist Market Size by Type (2018-2023)
6.2.2 North America Androgen Antagonist Market Size by Type (2024-2033)
6.2.3 North America Androgen Antagonist Market Share by Type (2018-2033)
6.3 North America Androgen Antagonist Market Size by Application
6.3.1 North America Androgen Antagonist Market Size by Application (2018-2023)
6.3.2 North America Androgen Antagonist Market Size by Application (2024-2033)
6.3.3 North America Androgen Antagonist Market Share by Application (2018-2033)
6.4 North America Androgen Antagonist Market Size by Country
6.4.1 North America Androgen Antagonist Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Androgen Antagonist Market Size by Country (2018-2023)
6.4.3 North America Androgen Antagonist Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Androgen Antagonist Market Size (2018-2033)
7.2 Europe Androgen Antagonist Market Size by Type
7.2.1 Europe Androgen Antagonist Market Size by Type (2018-2023)
7.2.2 Europe Androgen Antagonist Market Size by Type (2024-2033)
7.2.3 Europe Androgen Antagonist Market Share by Type (2018-2033)
7.3 Europe Androgen Antagonist Market Size by Application
7.3.1 Europe Androgen Antagonist Market Size by Application (2018-2023)
7.3.2 Europe Androgen Antagonist Market Size by Application (2024-2033)
7.3.3 Europe Androgen Antagonist Market Share by Application (2018-2033)
7.4 Europe Androgen Antagonist Market Size by Country
7.4.1 Europe Androgen Antagonist Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Androgen Antagonist Market Size by Country (2018-2023)
7.4.3 Europe Androgen Antagonist Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Androgen Antagonist Market Size (2018-2033)
8.2 China Androgen Antagonist Market Size by Type
8.2.1 China Androgen Antagonist Market Size by Type (2018-2023)
8.2.2 China Androgen Antagonist Market Size by Type (2024-2033)
8.2.3 China Androgen Antagonist Market Share by Type (2018-2033)
8.3 China Androgen Antagonist Market Size by Application
8.3.1 China Androgen Antagonist Market Size by Application (2018-2023)
8.3.2 China Androgen Antagonist Market Size by Application (2024-2033)
8.3.3 China Androgen Antagonist Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Androgen Antagonist Market Size (2018-2033)
9.2 Asia Androgen Antagonist Market Size by Type
9.2.1 Asia Androgen Antagonist Market Size by Type (2018-2023)
9.2.2 Asia Androgen Antagonist Market Size by Type (2024-2033)
9.2.3 Asia Androgen Antagonist Market Share by Type (2018-2033)
9.3 Asia Androgen Antagonist Market Size by Application
9.3.1 Asia Androgen Antagonist Market Size by Application (2018-2023)
9.3.2 Asia Androgen Antagonist Market Size by Application (2024-2033)
9.3.3 Asia Androgen Antagonist Market Share by Application (2018-2033)
9.4 Asia Androgen Antagonist Market Size by Region
9.4.1 Asia Androgen Antagonist Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Androgen Antagonist Market Size by Region (2018-2023)
9.4.3 Asia Androgen Antagonist Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Androgen Antagonist Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Androgen Antagonist Market Size by Type
10.2.1 Middle East, Africa, and Latin America Androgen Antagonist Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Androgen Antagonist Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Androgen Antagonist Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Androgen Antagonist Market Size by Application
10.3.1 Middle East, Africa, and Latin America Androgen Antagonist Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Androgen Antagonist Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Androgen Antagonist Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Androgen Antagonist Market Size by Country
10.4.1 Middle East, Africa, and Latin America Androgen Antagonist Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Androgen Antagonist Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Androgen Antagonist Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Androgen Antagonist Introduction
11.1.4 Pfizer Revenue in Androgen Antagonist Business (2018-2023)
11.1.5 Pfizer Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Androgen Antagonist Introduction
11.2.4 Johnson & Johnson Revenue in Androgen Antagonist Business (2018-2023)
11.2.5 Johnson & Johnson Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Androgen Antagonist Introduction
11.3.4 AstraZeneca Revenue in Androgen Antagonist Business (2018-2023)
11.3.5 AstraZeneca Recent Developments
11.4 Astellas
11.4.1 Astellas Company Details
11.4.2 Astellas Business Overview
11.4.3 Astellas Androgen Antagonist Introduction
11.4.4 Astellas Revenue in Androgen Antagonist Business (2018-2023)
11.4.5 Astellas Recent Developments
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Androgen Antagonist Introduction
11.5.4 Merck Revenue in Androgen Antagonist Business (2018-2023)
11.5.5 Merck Recent Developments
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Androgen Antagonist Introduction
11.6.4 Sanofi Revenue in Androgen Antagonist Business (2018-2023)
11.6.5 Sanofi Recent Developments
11.7 Orion Corporation
11.7.1 Orion Corporation Company Details
11.7.2 Orion Corporation Business Overview
11.7.3 Orion Corporation Androgen Antagonist Introduction
11.7.4 Orion Corporation Revenue in Androgen Antagonist Business (2018-2023)
11.7.5 Orion Corporation Recent Developments
11.8 Hengrui
11.8.1 Hengrui Company Details
11.8.2 Hengrui Business Overview
11.8.3 Hengrui Androgen Antagonist Introduction
11.8.4 Hengrui Revenue in Androgen Antagonist Business (2018-2023)
11.8.5 Hengrui Recent Developments
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Androgen Antagonist Introduction
11.9.4 Bayer Revenue in Androgen Antagonist Business (2018-2023)
11.9.5 Bayer Recent Developments
11.10 Schering-Plough
11.10.1 Schering-Plough Company Details
11.10.2 Schering-Plough Business Overview
11.10.3 Schering-Plough Androgen Antagonist Introduction
11.10.4 Schering-Plough Revenue in Androgen Antagonist Business (2018-2023)
11.10.5 Schering-Plough Recent Developments
11.11 Hinova Pharma
11.11.1 Hinova Pharma Company Details
11.11.2 Hinova Pharma Business Overview
11.11.3 Hinova Pharma Androgen Antagonist Introduction
11.11.4 Hinova Pharma Revenue in Androgen Antagonist Business (2018-2023)
11.11.5 Hinova Pharma Recent Developments
11.12 Jiangsu Hengrui Pharmaceuticals
11.12.1 Jiangsu Hengrui Pharmaceuticals Company Details
11.12.2 Jiangsu Hengrui Pharmaceuticals Business Overview
11.12.3 Jiangsu Hengrui Pharmaceuticals Androgen Antagonist Introduction
11.12.4 Jiangsu Hengrui Pharmaceuticals Revenue in Androgen Antagonist Business (2018-2023)
11.12.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Androgen Antagonist Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Steroidal Androgen Antagonist
Table 3. Key Players of Nonsteroidal Androgen Antagonist
Table 4. Global Androgen Antagonist Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Androgen Antagonist Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Androgen Antagonist Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Androgen Antagonist Market Share by Region (2018-2023)
Table 8. Global Androgen Antagonist Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Androgen Antagonist Market Share by Region (2024-2033)
Table 10. Androgen Antagonist Market Trends
Table 11. Androgen Antagonist Market Drivers
Table 12. Androgen Antagonist Market Challenges
Table 13. Androgen Antagonist Market Restraints
Table 14. Global Androgen Antagonist Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Androgen Antagonist Revenue Share by Players (2018-2023)
Table 16. Global Top Androgen Antagonist by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Antagonist as of 2022)
Table 17. Global Androgen Antagonist Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Androgen Antagonist Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Androgen Antagonist, Headquarters and Area Served
Table 20. Global Key Players of Androgen Antagonist, Product and Application
Table 21. Global Key Players of Androgen Antagonist, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Androgen Antagonist Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Androgen Antagonist Revenue Market Share by Type (2018-2023)
Table 25. Global Androgen Antagonist Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Androgen Antagonist Revenue Market Share by Type (2024-2033)
Table 27. Global Androgen Antagonist Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Androgen Antagonist Revenue Share by Application (2018-2023)
Table 29. Global Androgen Antagonist Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Androgen Antagonist Revenue Share by Application (2024-2033)
Table 31. North America Androgen Antagonist Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Androgen Antagonist Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Androgen Antagonist Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Androgen Antagonist Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Androgen Antagonist Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Androgen Antagonist Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Androgen Antagonist Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Androgen Antagonist Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Androgen Antagonist Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Androgen Antagonist Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Androgen Antagonist Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Androgen Antagonist Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Androgen Antagonist Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Androgen Antagonist Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Androgen Antagonist Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Androgen Antagonist Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Androgen Antagonist Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Androgen Antagonist Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Androgen Antagonist Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Androgen Antagonist Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Androgen Antagonist Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Androgen Antagonist Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Androgen Antagonist Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Androgen Antagonist Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Androgen Antagonist Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Androgen Antagonist Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Androgen Antagonist Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Androgen Antagonist Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Androgen Antagonist Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Androgen Antagonist Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Androgen Antagonist Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Androgen Antagonist Market Size by Country (2024-2033) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Androgen Antagonist Product
Table 66. Pfizer Revenue in Androgen Antagonist Business (2018-2023) & (US$ Million)
Table 67. Pfizer Recent Developments
Table 68. Johnson & Johnson Company Details
Table 69. Johnson & Johnson Business Overview
Table 70. Johnson & Johnson Androgen Antagonist Product
Table 71. Johnson & Johnson Revenue in Androgen Antagonist Business (2018-2023) & (US$ Million)
Table 72. Johnson & Johnson Recent Developments
Table 73. AstraZeneca Company Details
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Androgen Antagonist Product
Table 76. AstraZeneca Revenue in Androgen Antagonist Business (2018-2023) & (US$ Million)
Table 77. AstraZeneca Recent Developments
Table 78. Astellas Company Details
Table 79. Astellas Business Overview
Table 80. Astellas Androgen Antagonist Product
Table 81. Astellas Revenue in Androgen Antagonist Business (2018-2023) & (US$ Million)
Table 82. Astellas Recent Developments
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Androgen Antagonist Product
Table 86. Merck Revenue in Androgen Antagonist Business (2018-2023) & (US$ Million)
Table 87. Merck Recent Developments
Table 88. Sanofi Company Details
Table 89. Sanofi Business Overview
Table 90. Sanofi Androgen Antagonist Product
Table 91. Sanofi Revenue in Androgen Antagonist Business (2018-2023) & (US$ Million)
Table 92. Sanofi Recent Developments
Table 93. Orion Corporation Company Details
Table 94. Orion Corporation Business Overview
Table 95. Orion Corporation Androgen Antagonist Product
Table 96. Orion Corporation Revenue in Androgen Antagonist Business (2018-2023) & (US$ Million)
Table 97. Orion Corporation Recent Developments
Table 98. Hengrui Company Details
Table 99. Hengrui Business Overview
Table 100. Hengrui Androgen Antagonist Product
Table 101. Hengrui Revenue in Androgen Antagonist Business (2018-2023) & (US$ Million)
Table 102. Hengrui Recent Developments
Table 103. Bayer Company Details
Table 104. Bayer Business Overview
Table 105. Bayer Androgen Antagonist Product
Table 106. Bayer Revenue in Androgen Antagonist Business (2018-2023) & (US$ Million)
Table 107. Bayer Recent Developments
Table 108. Schering-Plough Company Details
Table 109. Schering-Plough Business Overview
Table 110. Schering-Plough Androgen Antagonist Product
Table 111. Schering-Plough Revenue in Androgen Antagonist Business (2018-2023) & (US$ Million)
Table 112. Schering-Plough Recent Developments
Table 113. Hinova Pharma Company Details
Table 114. Hinova Pharma Business Overview
Table 115. Hinova Pharma Androgen Antagonist Product
Table 116. Hinova Pharma Revenue in Androgen Antagonist Business (2018-2023) & (US$ Million)
Table 117. Hinova Pharma Recent Developments
Table 118. Jiangsu Hengrui Pharmaceuticals Company Details
Table 119. Jiangsu Hengrui Pharmaceuticals Business Overview
Table 120. Jiangsu Hengrui Pharmaceuticals Androgen Antagonist Product
Table 121. Jiangsu Hengrui Pharmaceuticals Revenue in Androgen Antagonist Business (2018-2023) & (US$ Million)
Table 122. Jiangsu Hengrui Pharmaceuticals Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Androgen Antagonist Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Androgen Antagonist Market Share by Type: 2022 VS 2033
Figure 3. Steroidal Androgen Antagonist Features
Figure 4. Nonsteroidal Androgen Antagonist Features
Figure 5. Global Androgen Antagonist Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Androgen Antagonist Market Share by Application: 2022 VS 2033
Figure 7. Prostate Cancer Case Studies
Figure 8. Benign Prostatic Hyperplasia Case Studies
Figure 9. Polycystic Ovary Syndrome (POCS) Case Studies
Figure 10. Others Case Studies
Figure 11. Androgen Antagonist Report Years Considered
Figure 12. Global Androgen Antagonist Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Androgen Antagonist Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Androgen Antagonist Market Share by Region: 2022 VS 2033
Figure 15. Global Androgen Antagonist Market Share by Players in 2022
Figure 16. Global Top Androgen Antagonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Antagonist as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Androgen Antagonist Revenue in 2022
Figure 18. North America Androgen Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Androgen Antagonist Market Share by Type (2018-2033)
Figure 20. North America Androgen Antagonist Market Share by Application (2018-2033)
Figure 21. North America Androgen Antagonist Market Share by Country (2018-2033)
Figure 22. United States Androgen Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Androgen Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Androgen Antagonist Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe Androgen Antagonist Market Share by Type (2018-2033)
Figure 26. Europe Androgen Antagonist Market Share by Application (2018-2033)
Figure 27. Europe Androgen Antagonist Market Share by Country (2018-2033)
Figure 28. Germany Androgen Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Androgen Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Androgen Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Androgen Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Androgen Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Androgen Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China Androgen Antagonist Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China Androgen Antagonist Market Share by Type (2018-2033)
Figure 36. China Androgen Antagonist Market Share by Application (2018-2033)
Figure 37. Asia Androgen Antagonist Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia Androgen Antagonist Market Share by Type (2018-2033)
Figure 39. Asia Androgen Antagonist Market Share by Application (2018-2033)
Figure 40. Asia Androgen Antagonist Market Share by Region (2018-2033)
Figure 41. Japan Androgen Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Androgen Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan Androgen Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Androgen Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Androgen Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Androgen Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Androgen Antagonist Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Androgen Antagonist Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America Androgen Antagonist Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America Androgen Antagonist Market Share by Country (2018-2033)
Figure 51. Brazil Androgen Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico Androgen Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey Androgen Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Androgen Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel Androgen Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries Androgen Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Androgen Antagonist Business (2018-2023)
Figure 58. Johnson & Johnson Revenue Growth Rate in Androgen Antagonist Business (2018-2023)
Figure 59. AstraZeneca Revenue Growth Rate in Androgen Antagonist Business (2018-2023)
Figure 60. Astellas Revenue Growth Rate in Androgen Antagonist Business (2018-2023)
Figure 61. Merck Revenue Growth Rate in Androgen Antagonist Business (2018-2023)
Figure 62. Sanofi Revenue Growth Rate in Androgen Antagonist Business (2018-2023)
Figure 63. Orion Corporation Revenue Growth Rate in Androgen Antagonist Business (2018-2023)
Figure 64. Hengrui Revenue Growth Rate in Androgen Antagonist Business (2018-2023)
Figure 65. Bayer Revenue Growth Rate in Androgen Antagonist Business (2018-2023)
Figure 66. Schering-Plough Revenue Growth Rate in Androgen Antagonist Business (2018-2023)
Figure 67. Hinova Pharma Revenue Growth Rate in Androgen Antagonist Business (2018-2023)
Figure 68. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in Androgen Antagonist Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries